The efficacy of intermittent dosing of statins is related to the observation that the duration of the total cholesterol and LDL-C lowering effects of these drugs is not re- lated to the pharmacokinetics of each individual statin. In light of the above-reported lesser impact of lower statin doses, compared to higher doses, on new-onset T2DM, one may speculate some advantage in this respect also by alternate-day statin, although large-scale clinical trials seem required to validate this hypothesis. It also needs to be underlined that the effect of alternate-day statin regimen on the pleiotropic effects of these drugs is still unknown [48].